Elicio Therapeutics Inc. (ELTX) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Elicio Therapeutics Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$1.85
+1.09% today
Market cap
$50M
Overall quality
35/100
Kronos AI 30-day
+32.1%
7 of 8 simulated paths end higher
Elicio Therapeutics Inc. (ELTX) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $50M. It trades at $1.85, up 1.09% today. Its overall quality score is 35 out of 100, ranked against the whole US market. 3 analysts' average target of $15.50 implies +737.8% from today's price. Kronos AI's 30-day forecast is +32.1% (7 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $15.50 |
| Low – high | $8.00 – $23.00 |
| Analysts | 3 |
| Upside to average | +737.8% |
Kronos AI 30-day forecast
| Expected close | $2.42 (+32.1%) |
| Likely range | +1.4% … +50.5% |
| As of | 2026-10-27 |
7 of 8 simulated paths end higher.
Quality scores
| Profitability | 34 |
| Solvency | 34 |
| Growth | 37 |
| Overall | 35 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.